Global Automatic Insulin Dosing Device Market Growth 2022-2028
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Automatic Insulin Dosing Device Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Automatic Insulin Dosing Device by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Automatic Insulin Dosing Device by Country/Region, 2017, 2022 & 2028
- 2.2 Automatic Insulin Dosing Device Segment by Type
- 2.2.1 Threshold Suspended Device Systems
- 2.2.2 Hybrid Closed-loop APDS
- 2.2.3 Other
- 2.3 Automatic Insulin Dosing Device Sales by Type
- 2.3.1 Global Automatic Insulin Dosing Device Sales Market Share by Type (2017-2022)
- 2.3.2 Global Automatic Insulin Dosing Device Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Automatic Insulin Dosing Device Sale Price by Type (2017-2022)
- 2.4 Automatic Insulin Dosing Device Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Home Care
- 2.4.4 Others
- 2.5 Automatic Insulin Dosing Device Sales by Application
- 2.5.1 Global Automatic Insulin Dosing Device Sale Market Share by Application (2017-2022)
- 2.5.2 Global Automatic Insulin Dosing Device Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Automatic Insulin Dosing Device Sale Price by Application (2017-2022)
3 Global Automatic Insulin Dosing Device by Company
- 3.1 Global Automatic Insulin Dosing Device Breakdown Data by Company
- 3.1.1 Global Automatic Insulin Dosing Device Annual Sales by Company (2020-2022)
- 3.1.2 Global Automatic Insulin Dosing Device Sales Market Share by Company (2020-2022)
- 3.2 Global Automatic Insulin Dosing Device Annual Revenue by Company (2020-2022)
- 3.2.1 Global Automatic Insulin Dosing Device Revenue by Company (2020-2022)
- 3.2.2 Global Automatic Insulin Dosing Device Revenue Market Share by Company (2020-2022)
- 3.3 Global Automatic Insulin Dosing Device Sale Price by Company
- 3.4 Key Manufacturers Automatic Insulin Dosing Device Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Automatic Insulin Dosing Device Product Location Distribution
- 3.4.2 Players Automatic Insulin Dosing Device Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Automatic Insulin Dosing Device by Geographic Region
- 4.1 World Historic Automatic Insulin Dosing Device Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Automatic Insulin Dosing Device Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Automatic Insulin Dosing Device Annual Revenue by Geographic Region
- 4.2 World Historic Automatic Insulin Dosing Device Market Size by Country/Region (2017-2022)
- 4.2.1 Global Automatic Insulin Dosing Device Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Automatic Insulin Dosing Device Annual Revenue by Country/Region
- 4.3 Americas Automatic Insulin Dosing Device Sales Growth
- 4.4 APAC Automatic Insulin Dosing Device Sales Growth
- 4.5 Europe Automatic Insulin Dosing Device Sales Growth
- 4.6 Middle East & Africa Automatic Insulin Dosing Device Sales Growth
5 Americas
- 5.1 Americas Automatic Insulin Dosing Device Sales by Country
- 5.1.1 Americas Automatic Insulin Dosing Device Sales by Country (2017-2022)
- 5.1.2 Americas Automatic Insulin Dosing Device Revenue by Country (2017-2022)
- 5.2 Americas Automatic Insulin Dosing Device Sales by Type
- 5.3 Americas Automatic Insulin Dosing Device Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Automatic Insulin Dosing Device Sales by Region
- 6.1.1 APAC Automatic Insulin Dosing Device Sales by Region (2017-2022)
- 6.1.2 APAC Automatic Insulin Dosing Device Revenue by Region (2017-2022)
- 6.2 APAC Automatic Insulin Dosing Device Sales by Type
- 6.3 APAC Automatic Insulin Dosing Device Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Automatic Insulin Dosing Device by Country
- 7.1.1 Europe Automatic Insulin Dosing Device Sales by Country (2017-2022)
- 7.1.2 Europe Automatic Insulin Dosing Device Revenue by Country (2017-2022)
- 7.2 Europe Automatic Insulin Dosing Device Sales by Type
- 7.3 Europe Automatic Insulin Dosing Device Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Automatic Insulin Dosing Device by Country
- 8.1.1 Middle East & Africa Automatic Insulin Dosing Device Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Automatic Insulin Dosing Device Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Automatic Insulin Dosing Device Sales by Type
- 8.3 Middle East & Africa Automatic Insulin Dosing Device Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Automatic Insulin Dosing Device
- 10.3 Manufacturing Process Analysis of Automatic Insulin Dosing Device
- 10.4 Industry Chain Structure of Automatic Insulin Dosing Device
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Automatic Insulin Dosing Device Distributors
- 11.3 Automatic Insulin Dosing Device Customer
12 World Forecast Review for Automatic Insulin Dosing Device by Geographic Region
- 12.1 Global Automatic Insulin Dosing Device Market Size Forecast by Region
- 12.1.1 Global Automatic Insulin Dosing Device Forecast by Region (2023-2028)
- 12.1.2 Global Automatic Insulin Dosing Device Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Automatic Insulin Dosing Device Forecast by Type
- 12.7 Global Automatic Insulin Dosing Device Forecast by Application
13 Key Players Analysis
- 13.1 Medtronic
- 13.1.1 Medtronic Company Information
- 13.1.2 Medtronic Automatic Insulin Dosing Device Product Offered
- 13.1.3 Medtronic Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Medtronic Main Business Overview
- 13.1.5 Medtronic Latest Developments
- 13.2 Dexcom
- 13.2.1 Dexcom Company Information
- 13.2.2 Dexcom Automatic Insulin Dosing Device Product Offered
- 13.2.3 Dexcom Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Dexcom Main Business Overview
- 13.2.5 Dexcom Latest Developments
- 13.3 Abbott
- 13.3.1 Abbott Company Information
- 13.3.2 Abbott Automatic Insulin Dosing Device Product Offered
- 13.3.3 Abbott Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Abbott Main Business Overview
- 13.3.5 Abbott Latest Developments
- 13.4 Insulet
- 13.4.1 Insulet Company Information
- 13.4.2 Insulet Automatic Insulin Dosing Device Product Offered
- 13.4.3 Insulet Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Insulet Main Business Overview
- 13.4.5 Insulet Latest Developments
- 13.5 Tandem Diabetes Care
- 13.5.1 Tandem Diabetes Care Company Information
- 13.5.2 Tandem Diabetes Care Automatic Insulin Dosing Device Product Offered
- 13.5.3 Tandem Diabetes Care Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Tandem Diabetes Care Main Business Overview
- 13.5.5 Tandem Diabetes Care Latest Developments
- 13.6 Bigfoot Biomedical
- 13.6.1 Bigfoot Biomedical Company Information
- 13.6.2 Bigfoot Biomedical Automatic Insulin Dosing Device Product Offered
- 13.6.3 Bigfoot Biomedical Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Bigfoot Biomedical Main Business Overview
- 13.6.5 Bigfoot Biomedical Latest Developments
- 13.7 Beta Bionics
- 13.7.1 Beta Bionics Company Information
- 13.7.2 Beta Bionics Automatic Insulin Dosing Device Product Offered
- 13.7.3 Beta Bionics Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Beta Bionics Main Business Overview
- 13.7.5 Beta Bionics Latest Developments
- 13.8 Admetsys
- 13.8.1 Admetsys Company Information
- 13.8.2 Admetsys Automatic Insulin Dosing Device Product Offered
- 13.8.3 Admetsys Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 Admetsys Main Business Overview
- 13.8.5 Admetsys Latest Developments
- 13.9 Defymed
- 13.9.1 Defymed Company Information
- 13.9.2 Defymed Automatic Insulin Dosing Device Product Offered
- 13.9.3 Defymed Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Defymed Main Business Overview
- 13.9.5 Defymed Latest Developments
- 13.10 Micro Tech Medical
- 13.10.1 Micro Tech Medical Company Information
- 13.10.2 Micro Tech Medical Automatic Insulin Dosing Device Product Offered
- 13.10.3 Micro Tech Medical Automatic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 Micro Tech Medical Main Business Overview
- 13.10.5 Micro Tech Medical Latest Developments
14 Research Findings and Conclusion
As the global economy mends, the 2021 growth of Automatic Insulin Dosing Device will have significant change from previous year. According to our (LP Information) latest study, the global Automatic Insulin Dosing Device market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Automatic Insulin Dosing Device market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Automatic Insulin Dosing Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Automatic Insulin Dosing Device market, reaching US$ million by the year 2028. As for the Europe Automatic Insulin Dosing Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Automatic Insulin Dosing Device players cover Medtronic, Dexcom, Abbott, and Insulet, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Automatic Insulin Dosing Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Home Care
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Medtronic
Dexcom
Abbott
Insulet
Tandem Diabetes Care
Bigfoot Biomedical
Beta Bionics
Admetsys
Defymed
Micro Tech Medical